Loading [MathJax]/jax/output/HTML-CSS/fonts/TeX/fontdata.js

Journal List > J Korean Bone Joint Tumor Soc > v.20(2) > 1052058

Oh, Lee, Jung, and Na: Osteosarcoma with Adenocarcinoma of Lung in Li-Fraumeni Syndrome: A Case Report

Abstract

Li-Fraumeni syndrome (LFS) is an autosomal dominant hereditary disorder characterised by a variety of different tumor types in children and young adults. That contains with a germline mutation in the tumor suppressor gene Tumor Protein p53 (TP53). That is extremely rare. Furthermore, this is sometimes overlooked. Here, we report a case of LFS which was confirmed by mutational analysis of the p53 gene. Also, literature review is intended to improve understanding of this disease entity.

Go to : Goto

References

1. Chompret A, Brugières L, Ronsin M, et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer. 2000; 82:1932–7.
2. Li FP, Fraumeni JF Jr. Prospective study of a family cancer syndrome. JAMA. 1982; 247:2692–4.
crossref
3. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998; 90:606–11.
crossref
4. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988; 48:5358–62.
5. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003; 21:2397–406.
6. Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet. 2005; 6:782–92.
crossref
7. Birch JM, Hartley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994; 54:1298–304.
8. Eeles RA. Germline mutations in the TP53 gene. Cancer Surv. 1995; 25:101–24.
9. Leroy K, Haioun C, Lepage E, et al. Groupe d'Etude des Lym-phomes de l'Adulte. p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas. Ann Oncol. 2002; 13:1108–15.
crossref
10. Berns EM, Foekens JA, Vossen R, et al. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res. 2000; 60:2155–62.
Go to : Goto

jkbjts-20-99f1.tif
Figure 1.
Plain radiographs showed the 4 cm sized eccentric bone-destructive lesion with permiative pattern on right proximal tibia and the Codman's triangle on lateral cortex.
undefined
jkbjts-20-99f2.tif
Figure 2.
On magnetic resonance imaging, there was 6×3 cm sized mass that have heterogenous signal intensity on T2-weighted (A) and T1-weighted image (B) GD (C) on lateral metaphysis of the proximal tibia. The periosteal reaction and the extraosseous formation was observed around the lateral cortex.
undefined
jkbjts-20-99f3.tif
Figure 3.
There are several small peripheral uncharacterized nodules in left lower lobe and right lower lobe of lung on enhanced chest CT.
undefined
jkbjts-20-99f4.tif
Figure 4.
On PET-CT imaging, there are multiple nodules in both lobe of lung.
undefined
jkbjts-20-99f5.tif
Figure 5.
Pedigree of family revealed multiple early onset cancer, including colon cancer, gastric cancer, neuroendocrine cancer and breast cancer.
undefined
jkbjts-20-99f6.tif
Figure 6.
Wide marginal excision and tumor prosthesis reconstruction was performed. Post-operative 2 years, there is no radiologic abnormality change of the implant.
undefined
TOOLS
Similar articles